Actualhealthapp.com

Mr. Jackson co-founded Vista Biomedical™ in 2023 and brings extensive experience in early-stage medical technology finance. He has raised over $75 million through public offerings, private placements, strategic partnerships, and bank financings. He is President of Bacchus Investors, LLC, a financial consulting firm for early-stage MedTech ventures. From 2010–2019, he served as Co-founder, Board Member, and CFO of St. Teresa Medical. He also co-founded PepTx, serving as Chairman, President, and CEO (1999–2004), and later as VP, CFO, and Director (2004–2016). Earlier, he was CFO and Controller at Everest Medical Corporation (1988–1994). Mr. Jackson holds a B.S.B. from the University of Minnesota and is co-inventor on three U.S. patents in hemostasis technology and one in cardiovascular technology.

Mr. Messina co-founded Vista Biomedical™ in 2023 and brings over 25 years of executive experience in early-stage MedTech and life sciences. His expertise spans regulatory affairs, licensing, M&A, distribution, and commercializing new technologies. He previously held leadership roles at St. Teresa Medical (Co-founder, Chair, CEO/COO/VP, 2010–2019), Martell Biosystems (President/COO, 2008–2010), and Gel-Del Technologies (COO, 2003–2008), where he secured a $15M license deal. From 1996–2003, he served as President/COO of UroMetrics and held CEO roles at Life Signs Corp. and Pulse Trend, successfully selling the latter for a 4.5x investor return. He began his career in healthcare sales. Mr. Messina holds a B.S. from Northeastern Illinois University and is co-inventor on 12+ medical technology patents.